Delivery Order SPE2DE24D0013-SPE2D625F0DAL
- Not listed
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,686.72 by the Defense Logistics Agency's Medical Supply Chain division on September 15, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order represents a purchase under an existing contract vehicle and carries no set-aside designation. Cepheid specializes in advanced diagnostic systems and test kits for infectious...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, received a delivery order award valued at $7,179.06 from the Defense Department's Medical Supply Chain division on September 17, 2025. This firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by October 1, 2025, and represents performance at Cepheid's Sunnyvale, CA facility. The award continues Cepheid's substantial engagement with federal healthcare systems,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $22,926.50 by the Medical Supply Chain division of the Department of Defense on September 8, 2025, with a completion date of September 15, 2025. The delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's...
- Cepheid has been awarded a delivery order valued at $4,078.80 by the Defense Logistics Agency's Medical Supply Chain division for performance in Sunnyvale, California. This firm fixed-price delivery order, issued on May 2, 2025 with an ultimate completion date of May 9, 2025, carries no set-aside designation. As a leading manufacturer of molecular diagnostic solutions, Cepheid specializes in GeneXpert diagnostic systems and related reagents, with a track record of supplying infectious disease...
- Cepheid, a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $18,433.60 by the Defense Logistics Agency's Medical Supply Chain division on September 22, 2025. The delivery order, which carries no set-aside designation, is scheduled for ultimate completion by September 29, 2025. This award represents a continuation of Cepheid's established relationship with federal healthcare agencies in supplying diagnostic...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0DALDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense agencies in supplying molecular diagnostic equipment, reagents, and testing solutions. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs, which include significant standing agreements valued at $32.8 million and $2.5 million respectively. Cepheid specializes in providing GeneXpert diagnostic systems and associated molecular reagents for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions across federal healthcare networks. The company's consistent engagement with the VA and Defense Logistics Agency underscores its competitive positioning in the federal molecular diagnostics procurement marketplace.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/4/25 |